Plain-English translation of NCT05372263 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a safety monitoring study for patients with pulmonary hypertension—a condition where blood pressure in the lungs becomes dangerously high. Researchers will follow at least 700 patients who are already taking pulmonary hypertension medications to carefully track how the medication is working and whether any side effects occur. The study uses a computerized system to keep in touch with patients every 6 months and collect important information about their health.
Pulmonary hypertension medications are life-saving treatments, but doctors need to continuously monitor how safe and effective they are when used in real-world patients over long periods. This study will help identify any safety concerns early and make sure the treatment is working well for people who need it.
You likely qualify if…
You likely don't qualify if…
You would continue taking your pulmonary hypertension medication as prescribed by your doctor. Every 6 months, you would check in with the research team—either in person or through the computerized follow-up system—to report how you are feeling, any side effects you've noticed, and answer questions about your health. The study will track you over time to watch for any adverse effects and monitor your overall health outcomes.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
China
Sponsor
China National Center for Cardiovascular Diseases
Enrollment target
~700 participants
Started
August 2021
Primary completion
August 2026
Age range
3 Months – 85 Years
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tingting Guo, M.D
Chinese Academy of Medical Sciences, Fuwai Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.